ES2141249T3 - PROCEDURE FOR THE IDENTIFICATION OF HUMAN AND ANIMAL CELLS THAT PRESENT THE CAPACITY FOR UNLIMITED PROLIFERATION OR FOR THE FORMATION OF TUMORS. - Google Patents

PROCEDURE FOR THE IDENTIFICATION OF HUMAN AND ANIMAL CELLS THAT PRESENT THE CAPACITY FOR UNLIMITED PROLIFERATION OR FOR THE FORMATION OF TUMORS.

Info

Publication number
ES2141249T3
ES2141249T3 ES94924756T ES94924756T ES2141249T3 ES 2141249 T3 ES2141249 T3 ES 2141249T3 ES 94924756 T ES94924756 T ES 94924756T ES 94924756 T ES94924756 T ES 94924756T ES 2141249 T3 ES2141249 T3 ES 2141249T3
Authority
ES
Spain
Prior art keywords
tumors
formation
identification
human
capacity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94924756T
Other languages
Spanish (es)
Inventor
Hinrich Johann Abken
Winfried Albert
Herbert Jungfer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2141249T3 publication Critical patent/ES2141249T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A COMPLEJOS DE PROTEINA DNA, PROTEINAS, SECUENCIAS DNA Y ANTICUERPOS QUE SON ADECUADOS PARA SU UTILIZACION EN LA DETECCION DE CELULAS CON CAPACIDAD DE PROLIFERACION ILIMITADA O DE FORMACION DE TUMORES, PROCESO PARA LA OBTENCION DE TALES PROTEINAS O SECUENCIAS DNA Y METODO DE IDENTIFICACION DE CELULAS HUMANAS Y ANIMALES CON CAPACIDAD DE PROLIFERACION ILIMITADA O DE FORMACION DE TUMORES, UTILIZANDO TALES PROTEINAS, SECUENCIAS DNA O ANTICUERPOS.THE INVENTION IS RELATED TO COMPLEXES OF DNA PROTEIN, PROTEINS, DNA SEQUENCES AND ANTIBODIES THAT ARE SUITABLE FOR USE IN THE DETECTION OF UNLIMITED PROLIFERATION CELLS OR FORMATION OF TUMORS, PROCESS FOR THE OBTAINING OF SUCH PROTEIN AND DNA PROTEINS OF IDENTIFICATION OF HUMAN AND ANIMAL CELLS WITH CAPACITY OF UNLIMITED PROLIFERATION OR FORMATION OF TUMORS, USING SUCH PROTEINS, DNA SEQUENCES OR ANTIBODIES.

ES94924756T 1993-07-15 1994-07-13 PROCEDURE FOR THE IDENTIFICATION OF HUMAN AND ANIMAL CELLS THAT PRESENT THE CAPACITY FOR UNLIMITED PROLIFERATION OR FOR THE FORMATION OF TUMORS. Expired - Lifetime ES2141249T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4323727A DE4323727A1 (en) 1993-07-15 1993-07-15 Method of identifying human and animal cells capable of unlimited proliferation or tumor formation

Publications (1)

Publication Number Publication Date
ES2141249T3 true ES2141249T3 (en) 2000-03-16

Family

ID=6492889

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94924756T Expired - Lifetime ES2141249T3 (en) 1993-07-15 1994-07-13 PROCEDURE FOR THE IDENTIFICATION OF HUMAN AND ANIMAL CELLS THAT PRESENT THE CAPACITY FOR UNLIMITED PROLIFERATION OR FOR THE FORMATION OF TUMORS.

Country Status (9)

Country Link
US (1) US6503706B1 (en)
EP (1) EP0708841B1 (en)
JP (1) JPH09500272A (en)
CN (1) CN1129958A (en)
AT (1) ATE186575T1 (en)
CA (1) CA2166976A1 (en)
DE (2) DE4323727A1 (en)
ES (1) ES2141249T3 (en)
WO (1) WO1995002701A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19509898A1 (en) * 1995-03-18 1997-06-05 Boehringer Mannheim Gmbh, 68305 Mannheim Method for measuring transcription-regulatory activities of DNA sequences
US6566583B1 (en) * 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
DE19725133A1 (en) * 1997-06-13 1998-12-17 Micromet Ges Fuer Biomedizinis Immuno-cyto-chemical detection of target cells
WO1999018235A1 (en) * 1997-10-07 1999-04-15 Hinrich Abken Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability
US7247461B2 (en) * 1999-01-14 2007-07-24 Martek Biosciences Corporation Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
US20070244192A1 (en) * 1999-01-14 2007-10-18 Martek Biosciences Corporation Plant seed oils containing polyunsaturated fatty acids
US7211418B2 (en) * 1999-01-14 2007-05-01 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US7217856B2 (en) * 1999-01-14 2007-05-15 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US8003772B2 (en) * 1999-01-14 2011-08-23 Martek Biosciences Corporation Chimeric PUFA polyketide synthase systems and uses thereof
AU2001283042A1 (en) * 2000-07-29 2002-02-13 Genaissance Pharmaceuticals, Inc. Haplotypes of the il12b gene
IL137905A0 (en) * 2000-08-16 2001-10-31 Nathan Citri Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen
DE10046318A1 (en) * 2000-09-19 2002-03-28 Hinrich Abken Detecting tumor cells from presence of specific stem-loop DNA molecules outside the nucleus, useful for diagnosis and monitoring of tumors
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
KR101524398B1 (en) 2006-03-15 2015-06-04 디에스엠 아이피 어셋츠 비.브이. Polyunsaturated Fatty Acid Production in Heterologous Organisms Using PUFA Polyketide Synthase Systems
ES2717102T3 (en) * 2009-03-19 2019-06-19 Dsm Ip Assets Bv Nucleic acid molecules of polyunsaturated fatty acid synthases, and polypeptides, compositions and methods of preparation and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6133199A (en) * 1984-05-25 1986-02-17 Asahi Chem Ind Co Ltd Polypeptide having gamma-interferon activity
DE4218945A1 (en) * 1992-06-10 1993-12-16 Boehringer Mannheim Gmbh DNA for immortalizing human or animal cells

Also Published As

Publication number Publication date
EP0708841A1 (en) 1996-05-01
DE4323727A1 (en) 1995-03-09
US6503706B1 (en) 2003-01-07
CA2166976A1 (en) 1995-01-26
CN1129958A (en) 1996-08-28
DE59408917D1 (en) 1999-12-16
WO1995002701A1 (en) 1995-01-26
JPH09500272A (en) 1997-01-14
EP0708841B1 (en) 1999-11-10
ATE186575T1 (en) 1999-11-15

Similar Documents

Publication Publication Date Title
ES2141249T3 (en) PROCEDURE FOR THE IDENTIFICATION OF HUMAN AND ANIMAL CELLS THAT PRESENT THE CAPACITY FOR UNLIMITED PROLIFERATION OR FOR THE FORMATION OF TUMORS.
BG100771A (en) HEMATOPOETIC PROTEIN AND MATERIALS AND METHODS FOR THEIR RECOVERY
DE69131961D1 (en) CLEANING OF PEPTIDES INTENDED FOR CLEANING
EA200001023A1 (en) SPECIFIC FOR FAPA- (PROTEIN ALPHA FIBROBE ACTIVATION) ANTIBODY WITH INCREASED PRODUCTIVITY
NO20014584D0 (en) Protein Isolation and Analysis
DK0961780T3 (en) Protein markers for lung cancer and its use
TR199900666T2 (en) Antibody to human parathormone-related peptides.
ATE332368T1 (en) SELECTION OF PROTEINS USING RNA-PROTEIN FUSIONS
DE69733247D1 (en) HUMANIZED GREEN FLUORESCENCE PROTEIN AND METHODS
FI900808A0 (en) HUMANT MANNOS BINDANDE PROTEIN.
ES2133813T3 (en) LAMININE CHAINS: DIAGNOSIS AND THERAPEUTIC USE.
DE69535719D1 (en) FAS-ANTIGEN-BINDING LIGAND
FI970979A0 (en) Modified human C3 proteins
NO885013D0 (en) PROCEDURE FOR THE MANUFACTURE OF BIODEGRADABLE MICROCAPLES OF WATER-PREPARABLE PEPTIDES AND PROTEINS, AS WELL AS MICROKA PSLS OBTAINED AT THE PROCEDURE.
SE8801701D0 (en) PRODUCTION TECHNOLOGY BASED ON ENZYMIC METHOD
FR2660757B1 (en) METHOD OF IDENTIFYING OR DETERMINING PROTEINS AND APPLICATIONS.
DE3881023D1 (en) PROTEINS, EXPRESSION VECTORS, CONTAINING DNA ENCODING SUCH PROTEINS, AND CELLS CONTAINING SUCH EXPRESSION VECTORS.
DK1082423T3 (en) Cyclin E2 genes and proteins
ATE265533T1 (en) MAMMAL CHEMOKINES
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
DE69734586D1 (en) RETINOID METABOLIZING PROTEIN
PT723552E (en) OLIGOPEPTIDES DERIVED FROM REAGENT PROTEIN FRAGMENTS
NO901461L (en) ANTIBODIES AGAINST RETINOBLASTOM REPRODUCT AND USE THEREOF.
ES2056872T3 (en) ANTICOAGULANT PROTEIN PP4-X, ITS PREPARATION AND USE.
EP0950062A4 (en) PROTEIN MARKER FOR ESOPHAGIC CANCER

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708841

Country of ref document: ES